Literature DB >> 33301529

Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study.

Raffaele Galiero1, Pia Clara Pafundi1, Vittorio Simeon2, Luca Rinaldi1, Alessandro Perrella3, Erica Vetrano1, Alfredo Caturano1, Maria Alfano1, Domenico Beccia1, Riccardo Nevola1,4, Raffaele Marfella1, Celestino Sardu1, Carmine Coppola5, Ferdinando Scarano5, Paolo Maggi6, Pellegrino De Lucia Sposito7, Laura Vocciante8, Carolina Rescigno9, Costanza Sbreglia10, Fiorentino Fraganza11, Roberto Parrella12, Annamaria Romano13, Giosuele Calabria14, Benedetto Polverino15, Antonio Pagano16, Carolina Bologna17, Maria Amitrano18, Vincenzo Esposito19, Nicola Coppola20, Nicola Maturo21, Luigi Elio Adinolfi1, Paolo Chiodini2, Ferdinando Carlo Sasso1.   

Abstract

BACKGROUND: Italy has been the first Western country to be heavily affected by the spread of SARS-COV-2 infection and among the pioneers of the clinical management of pandemic. To improve the outcome, identification of patients at the highest risk seems mandatory.
OBJECTIVES: Aim of this study is to identify comorbidities and clinical conditions upon admission associated with in-hospital mortality in several COVID Centers in Campania Region (Italy).
METHODS: COVOCA is a multicentre retrospective observational cohort study, which involved 18 COVID Centers throughout Campania Region, Italy. Data were collected from patients who completed their hospitalization between March-June 2020. The endpoint was in-hospital mortality, assessed either from data at discharge or death certificate, whilst all exposure variables were collected at hospital admission.
RESULTS: Among 618 COVID-19 hospitalized patients included in the study, 143 in-hospital mortality events were recorded, with a cumulative incidence of about 23%. At multivariable logistic analysis, male sex (OR 2.63, 95%CI 1.42-4.90; p = 0.001), Chronic Liver Disease (OR 5.88, 95%CI 2.39-14.46; p<0.001) and malignancies (OR 2.62, 95%CI 1.21-5.68; p = 0.015) disclosed an independent association with a poor prognosis, Glasgow Coma Scale (GCS) and Respiratory Severity Scale allowed to identify at higher mortality risk. Sensitivity analysis further enhanced these findings.
CONCLUSION: Mortality of patients hospitalized for COVID-19 appears strongly affected by both clinical conditions on admission and comorbidities. Originally, we observed a very poor outcome in subjects with a chronic liver disease, alongside with an increase of hepatic damage.

Entities:  

Year:  2020        PMID: 33301529     DOI: 10.1371/journal.pone.0243700

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  12 in total

Review 1.  Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Abraham Degarege; Zaeema Naveed; Josiane Kabayundo; David Brett-Major
Journal:  Pathogens       Date:  2022-05-10

2.  Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2.

Authors:  Jianguo Zhang; Jinhui Zhang; Zhimin Tao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-04       Impact factor: 6.055

Review 3.  Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement.

Authors:  Marcello Lanari; Elisabetta Venturini; Luca Pierantoni; Giacomo Stera; Guido Castelli Gattinara; Susanna Maria Roberta Esposito; Silvia Favilli; Emilio Franzoni; Eleonora Fusco; Paolo Lionetti; Claudio Maffeis; Gianluigi Marseglia; Laura Massella; Fabio Midulla; Alberto Zanobini; Marco Zecca; Alberto Villani; Annamaria Staiano; Luisa Galli
Journal:  Ital J Pediatr       Date:  2022-01-12       Impact factor: 2.638

4.  Predictors of Severity and Mortality in Chronic Liver Disease Patients With COVID-19 During the Second Wave of the Pandemic in India.

Authors:  Pankaj Nawghare; Shubham Jain; Sanjay Chandnani; Saurabh Bansal; Sameet Patel; Partha Debnath; Siddhesh Rane; Rahul Deshmukh; Pravin Rathi; Qais Contractor
Journal:  Cureus       Date:  2022-01-03

Review 5.  SARS-CoV-2 infection: a hurricane that does not ignore chronic hepatitis.

Authors:  Caterina Sagnelli; Margherita Macera; Clarissa Camaioni; Annabella Salvati; Nicola Coppola; Evangelista Sagnelli
Journal:  Infection       Date:  2022-03-22       Impact factor: 7.455

6.  Liver Function Tests in COVID-19: Assessment of the Actual Prognostic Value.

Authors:  Urszula Tokarczyk; Krzysztof Kaliszewski; Anna Kopszak; Łukasz Nowak; Karolina Sutkowska-Stępień; Maciej Sroczyński; Monika Sępek; Agata Dudek; Dorota Diakowska; Małgorzata Trocha; Damian Gajecki; Jakub Gawryś; Tomasz Matys; Justyna Maciejiczek; Valeriia Kozub; Roman Szalast; Marcin Madziarski; Anna Zubkiewicz-Zarębska; Krzysztof Letachowicz; Katarzyna Kiliś-Pstrusińska; Agnieszka Matera-Witkiewicz; Michał Pomorski; Marcin Protasiewicz; Janusz Sokołowski; Barbara Adamik; Krzysztof Kujawa; Adrian Doroszko; Katarzyna Madziarska; Ewa Anita Jankowska
Journal:  J Clin Med       Date:  2022-08-01       Impact factor: 4.964

Review 7.  COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis.

Authors:  Ramya Nagarajan; Yuvaraj Krishnamoorthy; Sathish Rajaa; Vishnu Shankar Hariharan
Journal:  Prev Chronic Dis       Date:  2022-08-25       Impact factor: 4.354

Review 8.  COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations.

Authors:  Abhishek Bhurwal; Carlos D Minacapelli; Evan Orosz; Kapil Gupta; Christopher Tait; Ishita Dalal; Clark Zhang; Eric Zhao; Vinod K Rustgi
Journal:  World J Gastroenterol       Date:  2021-12-14       Impact factor: 5.742

9.  Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study.

Authors:  Shimaa Afify; Basem Eysa; Fatma Abdel Hamid; Omnia M Abo-Elazm; Mohamed A Edris; Rabab Maher; Ahmed Abdelhalim; Muhammad Mostafa Abdel Ghaffar; Dalia A Omran; Hend Ibrahim Shousha
Journal:  World J Gastroenterol       Date:  2021-11-14       Impact factor: 5.742

Review 10.  Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis.

Authors:  Donovan A McGrowder; Fabian Miller; Melisa Anderson Cross; Lennox Anderson-Jackson; Sophia Bryan; Lowell Dilworth
Journal:  Diseases       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.